- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/545 - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine
Patent holdings for IPC class A61K 31/545
Total number of patents in this class: 355
10-year publication summary
29
|
34
|
25
|
43
|
35
|
26
|
31
|
21
|
15
|
6
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Sharp & Dohme LLC | 3689 |
14 |
Theriva Biologics, Inc. | 81 |
10 |
Meiji Seika Pharma Co., Ltd. | 244 |
9 |
Alpha 1 Biologics LLC | 6 |
6 |
The Regents of the University of California | 18943 |
5 |
Wockhardt Limited | 239 |
5 |
S.L.A. Pharma AG | 26 |
4 |
Theaprin Pharmaceuticals Inc. | 34 |
4 |
Trustees of Dartmouth College | 1016 |
4 |
VenatoRx Pharmaceuticals, Inc. | 81 |
4 |
Zoetis Services LLC | 1537 |
4 |
Centre National de La Recherche Scientifique | 9632 |
3 |
Bayer Animal Health GmbH | 300 |
3 |
The Board of Regents of the University of Oklahoma | 567 |
3 |
Harmonic Pharma | 7 |
3 |
Helperby Therapeutics Limited | 61 |
3 |
Insmed Incorporated | 207 |
3 |
Institut Curie | 531 |
3 |
Institute of Technology Sligo | 19 |
3 |
Intervet International B.V. | 1235 |
3 |
Other owners | 259 |